Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05048667 · ClinicalTrials.gov registry record · Phase 1
Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction
A Phase 1 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
NCT05048667 is a Phase 1 study that has completed, run by University of Miami. The registered enrollment target is 59 participants.
The verdict
NCT05048667, a Phase 1 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate whether the combination of Shock Wave Therapy (SWT) with Platelet Rich Plasma (PRP) is synergistic and can reverse the pathology of microvascular Erectile Dysfunction (ED) and enhance erectile function by improving vasodilation, and endothelial function
Interventions
- OTHER Placebo Saline
- DEVICE Shock Wave therapy (SWT)
- DRUG Platelet Rich Plasma (PRP)
- OTHER Sham SWT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2022-06-27 |
| Est. Completion | 2025-03-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05048667
The ClinicalTrials.gov registry entry for NCT05048667 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo Saline is the first listed.
NCT05048667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05048667 about?
NCT05048667 is a clinical study titled "Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction". The purpose of this research study is to evaluate whether the combination of Shock Wave Therapy (SWT) with Platelet Rich Plasma (PRP) is synergistic and can reverse the pathology of microvascular Erectile Dysfunction (ED) and enhance erectile function by improving vasodilation, and endothelial funct...
What is the current status of trial NCT05048667?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2022-06-27. Estimated completion is 2025-03-14.
What interventions are being tested in trial NCT05048667?
The interventions under investigation include: Placebo Saline (OTHER), Shock Wave therapy (SWT) (DEVICE), Platelet Rich Plasma (PRP) (DRUG), Sham SWT (OTHER).
Who is sponsoring clinical trial NCT05048667?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.